RESEARCHERS have identified p-tau217 as a powerful prognostic marker for cognitive impairment in people with idiopathic REM ...
UK pharma major GSK yesterday announced that the US Food and Drug Administration (FDA) has approved Exdensur ...
Exdensur is the first and only ultra-long-acting biologic for patients with severe asthma with an eosinophilic phenotype.
London: GSK has received approval from the US Food and Drug Administration (FDA) for Exdensur (depemokimab-ulaa) as an add-on ...
Depemokimab-ulaa (Exdensur) has been approved by the US FDA as add-on maintenance therapy for severe asthma with an ...
US FDA approves GSK’s Exdensur for the treatment of severe asthma: London, UK Thursday, December 18, 2025, 11:00 Hrs [IST] GSK plc announced that the US Food and Drug Administra ...
UK trial has found that azathioprine does not slow progression in early Parkinson’s disease, despite good tolerability. The ...
This year, psychological scientists tackled profound and varied questions to help us better understand ourselves and the ...
Background One in seven households in England live in accommodation not meeting housing quality standards. Low-quality ...
Modern Engineering Marvels on MSN
Shiller’s market signal hits dot-com levels as AI powers rally
Could the most reliable method of long-term stock price estimation be signaling today’s warning in the way it flashed just ...
Aya Gold & Silver Files Updated Technical Report For The Zgounder Silver Mine. MONTREAL, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the“Corporation”) ...
December 18, 2025) - CopperCorp Resources Inc. (TSXV: CPER) (OTCQB: CPCPF) ("CopperCorp" or the "Company") is pleased to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback